期刊
FERTILITY AND STERILITY
卷 101, 期 3, 页码 683-689出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2013.11.034
关键词
Assisted hatching; blastocyst transfer; GnRH-a suppression; monozygosity
资金
- NCI NIH HHS [R01 CA151973] Funding Source: Medline
Objective: To evaluate factors associated with monozygosity (MZ) (number of fetal heartbeats on early ultrasound greater than the number of embryos transferred) and the risk of recurrence in subsequent pregnancies using a national assisted reproduction database. Design: Historical cohort study. Setting: Clinic-based data. Patient(s): 197,327 pregnancies (including 2,824 with evidence of MZ) from cycles reported to the Society for Assisted Reproductive Technology Clinic Outcome Reporting System (SART CORS) between 2004 and 2010. Intervention(s): None. Main Outcome Measure(s): Evidence of MZ, adjusted odds ratios and their 95% confidence intervals computed from logistic regression models. Result(s): In the univariate analysis, the risk of MZ was increased with ovulation disorders, donor oocytes, gonadotropin-releasing hormone agonist (GnRH-a) suppression, assisted hatching (AZH), and day 5-6 transfer, and was decreased with higher folliclestimulating hormone (FSH) doses (>= 3,000 IU). In the multivariate analysis, the risk of MZ was increased with GnRH-a suppression, AZH, and decreased with intracytoplasmic sperm injection (ICSI) and higher FSH dose. The interaction showed that although MZ was more likely with day 5-6 embryos, AZH had a minimal nonsignificant effect, whereas in day 2-3 embryos, AZH had a substantial statistically significant effect. Only one woman had a recurrence of MZ in a subsequent assisted reproduction pregnancy, which is consistent with randomness. Conclusion(s): The risk of MZ was higher with fresh day 5-6 embryos, donor oocytes, GnRH-a suppression, lower FSH doses, and AZH (particularly with day 2-3 embryos). (C) 2014 by American Society for Reproductive Medicine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据